Researchers at DTU have patented a new invention that uses naturally produced substances from bifidobacteria in the gut to help lower the risk of allergies and asthma. Allergies and asthma are ...
India, Jan. 24 -- A clinical trial to determine the best intravenous (IV) treatments for children with severe asthma will go ...
WhiteSands Alcohol & Drug Rehab Orlando has published a new educational resource focused on treatment considerations during ...
WhiteSands Alcohol & Drug Rehab Tampa has published a new educational resource exploring the physiological effects of alcohol ...
As of Friday, January 23, Apogee Therapeutics, Inc.’s APGE share price has dipped by 8.67%, which has investors questioning ...
More than 140 U.S. medical organizations are advocating for the passage of a bill that would increase NIH funding for fiscal ...
Early Phase I data showed inhaled londamocitinib reduced airway inflammation in mild asthma with good tolerability. Learn ...
A woman has praised an urgent treatment centre (UTC) after it discovered she had a heart condition. Staff at the Corby UTC in ...
Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...
Apogee Therapeutics (APGE) leverages IL-13 pathway optimization to enable less frequent dosing, targeting a leadership shift ...
A new study shows that internet-delivered cognitive behavioral therapy (ICBT) can effectively reduce asthma-related anxiety ...
Proceeds to advance frevecitinib, an inhaled pan-JAK inhibitor with the potential to treat the broad severe asthma population, through Phase 2 studies ...